ICYMI: VGA039, a First-in-Class Antibody Therapy for VWD, Launched at ASH Annual Meeting
source: pixabay.com

ICYMI: VGA039, a First-in-Class Antibody Therapy for VWD, Launched at ASH Annual Meeting

  The 65th American Society of Hematology (ASH) Annual Meeting took place from December 10-13, 2022. During the meeting, stakeholders in the hematology field came together to discuss trends, research,…

Continue Reading ICYMI: VGA039, a First-in-Class Antibody Therapy for VWD, Launched at ASH Annual Meeting
High Rate of Bone Problems in Female Hemophilia Carriers
https://pixabay.com/en/skeleton-hand-bones-anatomy-joint-778069/

High Rate of Bone Problems in Female Hemophilia Carriers

In the past, researchers have observed a relationship between hemophilia and bone-related issues. However, while this observation is helpful, there have been few studies examining the prevalence of bone problems…

Continue Reading High Rate of Bone Problems in Female Hemophilia Carriers
New Study Looks At Bleeding Patterns of Infants and Toddlers With von Willebrand Disease
Source: Pixabay

New Study Looks At Bleeding Patterns of Infants and Toddlers With von Willebrand Disease

According to a recent article, researchers reported their findings from a new study that looked at the bleeding patterns and characteristics in infants and toddlers with von Willebrand disease (VWD).…

Continue Reading New Study Looks At Bleeding Patterns of Infants and Toddlers With von Willebrand Disease
March is Bleeding Disorders Awareness Month: Spreading Bleeding Disorders Awareness
source: pixabay.com

March is Bleeding Disorders Awareness Month: Spreading Bleeding Disorders Awareness

March is recognized each year as Bleeding Disorders Awareness Month, an event meant to help spread awareness about bleeding disorders among the general public and in the medical community. Bleeding…

Continue Reading March is Bleeding Disorders Awareness Month: Spreading Bleeding Disorders Awareness
Recall of Bleeding Disorder Drug Leaves Patients with Unanswered Questions
source: pixabay.com

Recall of Bleeding Disorder Drug Leaves Patients with Unanswered Questions

According to a story from hemophilia.org, the drug company Ferring Pharmaceuticals issued a recall of the nasal spray drug desmopressin (marketed as Stimate) on July 21st, 2020. This product is…

Continue Reading Recall of Bleeding Disorder Drug Leaves Patients with Unanswered Questions
Juvenile Male Patients with von Willebrand Disease More Likely to Experience Complications Than Female Counterparts
source: pixabay.com

Juvenile Male Patients with von Willebrand Disease More Likely to Experience Complications Than Female Counterparts

  The most common inherited bleeding disorder, von Willebrand disease, appears more likely to cause problems for juvenile males living with the disease than juvenile females, according to a study…

Continue Reading Juvenile Male Patients with von Willebrand Disease More Likely to Experience Complications Than Female Counterparts
Don’t Miss VWD Connect Foundation’s First-Ever Type 3/Severe Von Willebrand Disease Patient Conference
crystal710 / Pixabay

Don’t Miss VWD Connect Foundation’s First-Ever Type 3/Severe Von Willebrand Disease Patient Conference

Von Willebrand disease is the most common inherited blood clotting disorder that affects humans. The disorder can also be acquired. Although it is considered common, the majority of cases do…

Continue Reading Don’t Miss VWD Connect Foundation’s First-Ever Type 3/Severe Von Willebrand Disease Patient Conference

Victory for Women’s 2018 NOW Conference

  • Post author:
  • Post category:

2018 National Outreach for Von Willebrand Conference This event will be a chance for patients with Von Willebrand's disease to learn more about how to manage living with this disease…

Continue Reading Victory for Women’s 2018 NOW Conference
Prophylaxis May Reduce the Need of Hospitalization for von Willebrand Disease Patients, Study Says
source: pixabay.com

Prophylaxis May Reduce the Need of Hospitalization for von Willebrand Disease Patients, Study Says

According to a story from the National Hemophilia Foundation, a collaborative team of researchers from the U.S. and Sweden recently announced the results of a study the indicated that a…

Continue Reading Prophylaxis May Reduce the Need of Hospitalization for von Willebrand Disease Patients, Study Says